Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Notfall +  Rettungsmedizin 4/2013

01.06.2013 | Notfall aktuell - Für Sie gelesen

Serelaxin zur Therapie der akuten Herzinsuffizienz (RELAX-AHF)

Eine vielversprechende Option?

verfasst von: Prof. Dr. M. Christ, J. Schmidt

Erschienen in: Notfall + Rettungsmedizin | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Auszug

Teerlink JR, Cotter G, Davison BA et al (2012) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet doi:10.1016/S0140-6736(12)61855-8 (Early Online Publication) …
Literatur
1.
Zurück zum Zitat Authors/Task Force Members, McMurray JJV, Adamopoulos S et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847 CrossRef Authors/Task Force Members, McMurray JJV, Adamopoulos S et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847 CrossRef
2.
Zurück zum Zitat Cotter G, Metra M, Milo-Cotter O et al (2008) Fluid overload in acute heart failure – re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165–169 PubMedCrossRef Cotter G, Metra M, Milo-Cotter O et al (2008) Fluid overload in acute heart failure – re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165–169 PubMedCrossRef
3.
Zurück zum Zitat Du XJ, Bathgate RA, Samuel CS et al (2010) Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol 7:48–58 PubMedCrossRef Du XJ, Bathgate RA, Samuel CS et al (2010) Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol 7:48–58 PubMedCrossRef
4.
Zurück zum Zitat Konstam MA, Thethi T, Fonseca V et al (2012) RELAX-AHF: rising from the doldrums in acute heart failure Lancet 381:5–6 Konstam MA, Thethi T, Fonseca V et al (2012) RELAX-AHF: rising from the doldrums in acute heart failure Lancet 381:5–6
6.
Zurück zum Zitat Roger VL, Go AS, Lloyd-Jones DM et al (2012) Executive summary: heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 125:188–197 PubMedCrossRef Roger VL, Go AS, Lloyd-Jones DM et al (2012) Executive summary: heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 125:188–197 PubMedCrossRef
7.
Zurück zum Zitat Teerlink JR, Cotter G, Davison BA et al (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381:29–39 PubMedCrossRef Teerlink JR, Cotter G, Davison BA et al (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381:29–39 PubMedCrossRef
8.
Zurück zum Zitat Metra M, Cotter G, Davison BA et al (2013) Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61:196–206 PubMedCrossRef Metra M, Cotter G, Davison BA et al (2013) Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61:196–206 PubMedCrossRef
9.
Zurück zum Zitat Breidthardt T, Noveanu M, Potocki M et al (2010) Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study. J Intern Med 267(3):322–330 PubMedCrossRef Breidthardt T, Noveanu M, Potocki M et al (2010) Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: a pilot study. J Intern Med 267(3):322–330 PubMedCrossRef
Metadaten
Titel
Serelaxin zur Therapie der akuten Herzinsuffizienz (RELAX-AHF)
Eine vielversprechende Option?
verfasst von
Prof. Dr. M. Christ
J. Schmidt
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Notfall + Rettungsmedizin / Ausgabe 4/2013
Print ISSN: 1434-6222
Elektronische ISSN: 1436-0578
DOI
https://doi.org/10.1007/s10049-012-1682-6